177 related articles for article (PubMed ID: 23251525)
1. Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.
Peng B; Gu Y; Xiong Y; Zheng G; He Z
PLoS One; 2012; 7(12):e51413. PubMed ID: 23251525
[TBL] [Abstract][Full Text] [Related]
2. TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.
Gu Y; Fan S; Liu B; Zheng G; Yu Y; Ouyang Y; He Z
Mol Cell Biochem; 2011 Nov; 357(1-2):107-13. PubMed ID: 21603883
[TBL] [Abstract][Full Text] [Related]
3. Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Peng B; Yi S; Gu Y; Zheng G; He Z
Protein Expr Purif; 2012 Apr; 82(2):360-7. PubMed ID: 22365988
[TBL] [Abstract][Full Text] [Related]
4. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
5. TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.
Liu X; Wang C; Gu Y; Zhang Z; Zheng G; He Z
Mol Cell Biochem; 2015 Jan; 398(1-2):175-83. PubMed ID: 25260657
[TBL] [Abstract][Full Text] [Related]
6. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
7. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.
Huang Z; Zhang Y; Li H; Zhou Y; Zhang Q; Chen R; Jin T; Hu K; Li S; Wang Y; Chen W; Huang Z
Cell Death Dis; 2019 Dec; 10(12):936. PubMed ID: 31819048
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
Zhou X; Zhang Z; Yang X; Chen W; Zhang P
Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
[TBL] [Abstract][Full Text] [Related]
11. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.
Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY
Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830
[TBL] [Abstract][Full Text] [Related]
12. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.
Jia X; Zhang Z; Luo K; Zheng G; Lu M; Song Y; Liu H; Qiu H; He Z
Sci Rep; 2017 Jun; 7(1):3744. PubMed ID: 28623290
[TBL] [Abstract][Full Text] [Related]
13. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathway.
Duarte VM; Han E; Veena MS; Salvado A; Suh JD; Liang LJ; Faull KF; Srivatsan ES; Wang MB
Mol Cancer Ther; 2010 Oct; 9(10):2665-75. PubMed ID: 20937593
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species.
Magnano S; Hannon Barroeta P; Duffy R; O'Sullivan J; Zisterer DM
Toxicol Appl Pharmacol; 2021 Sep; 427():115646. PubMed ID: 34274415
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
[TBL] [Abstract][Full Text] [Related]
17. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
18. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.
Hasan R; Chauhan SS; Sharma R; Ralhan R
World J Gastroenterol; 2012 Aug; 18(31):4127-35. PubMed ID: 22919244
[TBL] [Abstract][Full Text] [Related]
20. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
